Connect
MJA
MJA

Medicinal cannabis in Australia: the missing links

Albert S Reece and Gary K Hulse
Med J Aust 2016; 205 (9): 425. || doi: 10.5694/mja16.00709
Published online: 7 November 2016

The well researched article by Martin and Bonomo1 may provide the Australian government with the kind of safety and efficacy data mandatory for all new drugs marketed to human populations. However, the authors did not discuss the efficacy of cannabis compared with that of accepted safe medicines; this applies to most of the indications that have been alleged but not proven for cannabis, including pain, spasticity, anticonvulsant action, weight gain and antiglaucoma agents.

  • Albert S Reece
  • Gary K Hulse

  • University of Western Australia, Perth, WA

Correspondence: sreece@bigpond.net.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.